FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1877-1882 December 27, 2001 Number 26 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background It is probable but unproven that Epstein–Barr virus (EBV) has a role in nasopharyngeal carcinoma. We determined whether antibodies against EBV are present before the development of nasopharyngeal carcinoma.

Methods A total of 9699 men were enrolled between 1984 and 1986. Blood samples were examined for IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV-specific DNase. During 131,981 person-years of follow-up, 22 pathologically confirmed new cases of nasopharyngeal carcinoma that were diagnosed more than one year after recruitment were ascertained through linkage with the National Cancer Registry of Taiwan.

Results The cumulative risk of nasopharyngeal carcinoma per 100,000 person-years was 11.2 for subjects who tested positive for neither serologic marker, 45.0 for those who had one marker, and 371.0 for those who had both markers. After adjustment for age and the presence or absence of a family history of nasopharyngeal carcinoma, the relative risk of nasopharyngeal carcinoma was 32.8 for subjects with both markers (95 percent confidence interval, 7.3 to 147.2; P<0.001) and 4.0 for subjects with one marker (95 percent confidence interval, 1.6 to 10.2; P=0.003), as compared with subjects with neither marker. The longer the duration of follow-up, the greater the difference in the cumulative incidence of nasopharyngeal carcinoma between seropositive and seronegative subjects.

Conclusions IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV DNase are predictive of nasopharyngeal carcinoma.

Source Information

From the Graduate Institute of Epidemiology, College of Public Health (Y.-C.C., H.Y., C.-J.C.), the Graduate Institute of Microbiology (J.-Y.C., C.-S.Y.), and the Department of Otolaryngology (M.-M.H.), College of Medicine, National Taiwan University, Taipei; and the Department of General Education, National Taipei College of Nursing, Taipei (M.-Y.L.) — all in Taiwan.

Address reprint requests to Dr. Chien-Jen Chen at the Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 1 Jen-Ai Rd., Sec. 1, Taipei 100, Taiwan, or at cjchen{at}ha.mc.ntu.edu.tw.

Full Text of this Article

This article has been cited by other articles:

• Delbende, C., Verwaerde, C., Mougel, A., Tranchand Bunel, D. (2009). Induction of Therapeutic Antibodies by Vaccination against External Loops of Tumor-Associated Viral Latent Membrane Protein. J. Virol. 83: 11734-11745 [Abstract] [Full Text]  
• Paramita, D. K., Fachiroh, J., Haryana, S. M., Middeldorp, J. M. (2009). Two-Step Epstein-Barr Virus Immunoglobulin A Enzyme-Linked Immunosorbent Assay System for Serological Screening and Confirmation of Nasopharyngeal Carcinoma. CVI 16: 706-711 [Abstract] [Full Text]  
• Hsu, W.-L., Chen, J.-Y., Chien, Y.-C., Liu, M.-Y., You, S.-L., Hsu, M.-M., Yang, C.-S., Chen, C.-J. (2009). Independent Effect of EBV and Cigarette Smoking on Nasopharyngeal Carcinoma: A 20-Year Follow-Up Study on 9,622 Males without Family History in Taiwan. Cancer Epidemiol. Biomarkers Prev. 18: 1218-1226 [Abstract] [Full Text]  
• Gu, A.-D., Mo, H.-Y., Xie, Y.-B., Peng, R.-J., Bei, J.-X., Peng, J., Li, M.-Y., Chen, L.-Z., Feng, Q.-S., Jia, W.-H., Zeng, Y.-X. (2008). Evaluation of a Multianalyte Profiling Assay and an Enzyme-Linked Immunosorbent Assay for Serological Examination of Epstein-Barr Virus-Specific Antibody Responses in Diagnosis of Nasopharyngeal Carcinoma. CVI 15: 1684-1688 [Abstract] [Full Text]  
• Chang, S.-S., Lo, Y.-C., Chua, H.-H., Chiu, H.-Y., Tsai, S.-C., Chen, J.-Y., Lo, K.-W., Tsai, C.-H. (2008). Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta Expression. J. Virol. 82: 7745-7751 [Abstract] [Full Text]  
• Maloney, W. J., Weinberg, M. A. (2008). A Comprehensive Analysis of Babe Ruth's Head and Neck Cancer. Journal of the American Dental Association 139: 926-932 [Abstract] [Full Text]  
• Yang, P.-W., Chang, S.-S., Tsai, C.-H., Chao, Y.-H., Chen, M.-R. (2008). Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J. Gen. Virol. 89: 884-895 [Abstract] [Full Text]  
• Hsu, M., Wu, S.-Y., Chang, S.-S., Su, I.-J., Tsai, C.-H., Lai, S.-J., Shiau, A.-L., Takada, K., Chang, Y. (2008). Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells. J. Virol. 82: 3679-3688 [Abstract] [Full Text]  
• Fachiroh, J., Prasetyanti, P. R., Paramita, D. K., Prasetyawati, A. T., Anggrahini, D. W., Haryana, S. M., Middeldorp, J. M. (2008). Dried-Blood Sampling for Epstein-Barr Virus Immunoglobulin G (IgG) and IgA Serology in Nasopharyngeal Carcinoma Screening. J. Clin. Microbiol. 46: 1374-1380 [Abstract] [Full Text]  
• Choong, N., Vokes, E. (2008). Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer. CA Cancer J Clin 58: 32-53 [Abstract] [Full Text]  
• Ho, C.-H., Hsu, C.-F., Fong, P.-F., Tai, S.-K., Hsieh, S.-L., Chen, C.-J. (2007). Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter. J. Virol. 81: 4837-4847 [Abstract] [Full Text]  
• Chang, E. T., Adami, H.-O. (2006). The enigmatic epidemiology of nasopharyngeal carcinoma.. Cancer Epidemiol. Biomarkers Prev. 15: 1765-1777 [Abstract] [Full Text]  
• Leung, D. T. M., van Maren, W. W. C., Chan, F. K. L., Chan, W. S., Lo, A. W. I., Ma, C. H., Tam, F. C. H., To, K. F., Chan, P. K. S., Sung, J. J. Y., Lim, P. L. (2006). Extremely Low Exposure of a Community to Severe Acute Respiratory Syndrome Coronavirus: False Seropositivity due to Use of Bacterially Derived Antigens.. J. Virol. 80: 8920-8928 [Abstract] [Full Text]  
• Fachiroh, J., Paramita, D. K., Hariwiyanto, B., Harijadi, A., Dahlia, H. L., Indrasari, S. R., Kusumo, H., Zeng, Y. S., Schouten, T., Mubarika, S., Middeldorp, J. M. (2006). Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field Screening. J. Clin. Microbiol. 44: 1459-1467 [Abstract] [Full Text]  
• Butsch Kovacic, M., Martin, M., Gao, X., Fuksenko, T., Chen, C.-J., Cheng, Y.-J., Chen, J.-Y., Apple, R., Hildesheim, A., Carrington, M. (2005). Variation of the Killer Cell Immunoglobulin-Like Receptors and HLA-C Genes in Nasopharyngeal Carcinoma. Cancer Epidemiol. Biomarkers Prev. 14: 2673-2677 [Abstract] [Full Text]  
• Levin, L. I., Munger, K. L., Rubertone, M. V., Peck, C. A., Lennette, E. T., Spiegelman, D., Ascherio, A. (2005). Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis. JAMA 293: 2496-2500 [Abstract] [Full Text]  
• Tung, C. J., Wang, H. C., Lo, S. H., Wu, J. M., Wang, C. J. (2004). In vivo dosimetry for external photon treatments of head and neck cancers by diodes and TLDS. Radiat Prot Dosimetry 111: 45-50 [Abstract] [Full Text]  
• Lin, J.-C., Wang, W.-Y., Chen, K. Y., Wei, Y.-H., Liang, W.-M., Jan, J.-S., Jiang, R.-S. (2004). Quantification of Plasma Epstein-Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma. NEJM 350: 2461-2470 [Abstract] [Full Text]  
• Chang, Y., Chang, S.-S., Lee, H.-H., Doong, S.-L., Takada, K., Tsai, C.-H. (2004). Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference. J. Gen. Virol. 85: 1371-1379 [Abstract] [Full Text]  
• Lo, S., Ho, W.-K., Wei, W. I. (2004). Outcome of Patients With Positive Epstein-Barr Virus Serologic Status in the Absence of Nasopharyngeal Carcinoma in Hong Kong. Arch Otolaryngol Head Neck Surg 130: 770-772 [Abstract] [Full Text]  
• Wong, T.-S., Kwong, D. L.-W., Sham, J. S.-T., Wei, W. I., Kwong, Y.-L., Yuen, A. P.-W. (2004). Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma. Clin. Cancer Res. 10: 2401-2406 [Abstract] [Full Text]  
• Leung, S.-f., Tam, J. S., Chan, A. T.C., Zee, B., Chan, L. Y.S., Huang, D. P., Van Hasselt, A., Johnson, P. J., Lo, Y.M. D. (2004). Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein-Barr Virus DNA and Anti-Epstein-Barr Viral Capsid Antigen IgA Antibody. Clin. Chem. 50: 339-345 [Abstract] [Full Text]  
• Cho, E.-Y., Hildesheim, A., Chen, C.-J., Hsu, M.-M., Chen, I-H., Mittl, B. F., Levine, P. H., Liu, M.-Y., Chen, J.-Y., Brinton, L. A., Cheng, Y.-J., Yang, C.-S. (2003). Nasopharyngeal Carcinoma and Genetic Polymorphisms of DNA Repair Enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. 12: 1100-1104 [Abstract] [Full Text]  
• Levin, L. I., Munger, K. L., Rubertone, M. V., Peck, C. A., Lennette, E. T., Spiegelman, D., Ascherio, A. (2003). Multiple Sclerosis and Epstein-Barr Virus. JAMA 289: 1533-1536 [Abstract] [Full Text]  
• Hildesheim, A., Apple, R. J., Chen, C.-J., Wang, S. S., Cheng, Y.-J., Klitz, W., Mack, S. J., Chen, I-H., Hsu, M.-M., Yang, C.-S., Brinton, L. A., Levine, P. H., Erlich, H. A. (2002). Association of HLA Class I and II Alleles and Extended Haplotypes With Nasopharyngeal Carcinoma in Taiwan. JNCI J Natl Cancer Inst 94: 1780-1789 [Abstract] [Full Text]  
• Forastiere, A., Koch, W., Trotti, A., Sidransky, D. (2001). Head and Neck Cancer. NEJM 345: 1890-1900 [Full Text]